Comparing the costs and diagnostic outcomes of using DNA methylation testing instead of liquid-based cytology within HPV primary cervical cancer screening in the Netherlands. Read Summary → Read Publication
Publication of our research assessing the potential health and economic benefits of improved management of chronic obstructive pulmonary disease in England, Germany, Canada, and Japan. Read Summary → Read Publication
Publication of our economic evaluation comparing two cervical screening strategies in Belgium: HPV primary versus co-testing Read Summary → Read Publication
An economic evaluation of two PCR-based respiratory panel assays for patients admitted to hospital with community-acquired pneumonia (CAP) in the UK, France, and Spain Read Summary → Read Publication
Piss in a pot and pop it in the post: An economic evaluation of vaginal swab and urine self-sampling for HPV primary cervical cancer screening compared with clinician-collected sampling Read Summary → Read Publication
The cost-effectiveness of Magnetic Resonance-Guided Focused Ultrasound compared to Deep Brain Stimulation for the treatment of essential tremor Read Summary → Read Publication
Cost-effectiveness of a rapid point-of-care test for diagnosing patients with suspected bloodstream infection in Ireland Read Summary → Read Publication
Health economic evaluation of an mRNA HR-HPV assay versus a DNA HR-HPV assay for the proposed French cervical screening programme Read Summary → Read Publication
Identifying the common barriers to optimal COPD care in Japan, Canada, England, and Germany through Evidenced Care Pathways Read Summary → Read Publication
A health economic model to estimate the costs and benefits of an mRNA vs DNA high-risk HPV assay in a hypothetical HPV primary screening algorithm in Ontario, Canada Read Summary → Read Publication